NO824285L - Fremgangsmaate ved fremstilling av stabiliserte interferonpreparater. - Google Patents

Fremgangsmaate ved fremstilling av stabiliserte interferonpreparater.

Info

Publication number
NO824285L
NO824285L NO824285A NO824285A NO824285L NO 824285 L NO824285 L NO 824285L NO 824285 A NO824285 A NO 824285A NO 824285 A NO824285 A NO 824285A NO 824285 L NO824285 L NO 824285L
Authority
NO
Norway
Prior art keywords
procedure
preparation
interferon preparations
stabilized interferon
stabilized
Prior art date
Application number
NO824285A
Other languages
English (en)
Other versions
NO161036C (no
NO161036B (no
Inventor
Henry King Hong Kwan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26989028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO824285(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ZA828580A external-priority patent/ZA828580B/xx
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO824285L publication Critical patent/NO824285L/no
Publication of NO161036B publication Critical patent/NO161036B/no
Publication of NO161036C publication Critical patent/NO161036C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
NO82824285A 1981-12-23 1982-12-20 Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat. NO161036C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations

Publications (3)

Publication Number Publication Date
NO824285L true NO824285L (no) 1983-06-24
NO161036B NO161036B (no) 1989-03-20
NO161036C NO161036C (no) 1989-06-28

Family

ID=26989028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO82824285A NO161036C (no) 1981-12-23 1982-12-20 Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat.

Country Status (18)

Country Link
US (1) US4496537A (no)
EP (1) EP0082481B2 (no)
AU (1) AU558966B2 (no)
CA (1) CA1207665A (no)
DE (1) DE3262575D1 (no)
DK (1) DK158873C (no)
FI (1) FI70794C (no)
HK (1) HK94487A (no)
HU (1) HU190649B (no)
IE (1) IE54468B1 (no)
IL (1) IL67517A (no)
MY (1) MY8700705A (no)
NO (1) NO161036C (no)
NZ (1) NZ202856A (no)
OA (1) OA07282A (no)
PH (1) PH19869A (no)
PT (1) PT76013B (no)
SG (1) SG70687G (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600583A (en) * 1982-09-07 1986-07-15 Tetra Consultants Inc. Pharmaceutical compositions
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
EP0168008A3 (en) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4847079A (en) * 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4871538A (en) * 1987-07-13 1989-10-03 Schering Corporation Insoluble copper-alpha interferon complex
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
ATE90570T1 (de) * 1988-01-29 1993-07-15 Sumitomo Pharma Verbesserte formulierungen mit kontrollierter abgabe.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
IT1240314B (it) * 1989-09-28 1993-12-07 Immunobiology Research Institutes, Inc. Formulazioni acquose stabilizzate di piccoli peptidi.
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
AU669132B2 (en) * 1991-10-11 1996-05-30 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
WO1993006856A1 (en) * 1991-10-11 1993-04-15 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Ｉｌ−１２用処方
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
JP4878664B2 (ja) * 1996-12-24 2012-02-15 バイオジェン・アイデック・エムエイ・インコーポレイテッド 安定な液体インターフェロン処方物
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
CA2304808C (en) 1997-09-23 2011-03-22 Michael Tschope Liquid interferon-.beta. formulations
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
AU1361399A (en) * 1997-10-14 1999-05-03 Eisai Co. Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
US8563803B2 (en) * 1997-10-16 2013-10-22 Synageva Biopharma Corp. Method of making protein in an egg of a transgenic chicken
US20090074718A1 (en) * 1997-10-16 2009-03-19 Ivarie Robert D Avian derived erythropoietin
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
US7511120B2 (en) * 1997-10-16 2009-03-31 Synageva Biopharma Corp. Glycosylated G-CSF obtained from a transgenic chicken
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
CN101255188A (zh) 1998-11-12 2008-09-03 先灵公司 干扰素同种型的转化方法及其产物
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
KR100771294B1 (ko) * 1999-12-14 2007-10-29 써모 바이오스타, 인크. 폴리펩티드 및 항원 안정화 희석제
CA2427850A1 (en) 2000-11-03 2002-05-10 Sidney Pestka Interferons, uses and compositions related thereto
CA2433037C (en) 2000-12-28 2010-12-21 Takeda Chemical Industries, Ltd. Sustained-release preparation
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
EE05509B1 (et) 2002-01-18 2012-02-15 Biogen@Idec@Ma@Inc Aktiveeritud polalkleenglkoolpolmeer ja seda sisaldavad kompositsioonid
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US7803362B2 (en) * 2003-01-24 2010-09-28 Synageva Biopharma Corp. Glycosylated interferon alpha
CA2518903C (en) * 2003-04-02 2013-02-05 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
WO2004112826A1 (en) * 2003-06-20 2004-12-29 Ares Trading Sa Freeze-dried fsh / lh formulations
DE602005022895D1 (de) * 2004-08-12 2010-09-23 Schering Corp Stabile pegylierte interferon-formulierung
WO2006091038A1 (en) * 2005-02-25 2006-08-31 Medigenes Co., Ltd. Pharmaceutical composition for treating avellino cornea dystrophy comprising blood plasma or serum
US8124732B2 (en) 2005-06-24 2012-02-28 Synageva Biopharma Corp. Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
US20070003564A1 (en) * 2005-06-30 2007-01-04 Hurley John K Diluent for immunohistochemistry
US7931919B2 (en) * 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
CU23432B6 (es) 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
US7812127B2 (en) 2006-03-17 2010-10-12 Synageva Biopharma Corp. Glycosylated human G-CSF
US20090105462A1 (en) * 2006-11-09 2009-04-23 Ivarie Robert D Glycosylated erythropoietin
PL2097068T3 (pl) * 2006-11-24 2013-12-31 Cadila Healthcare Ltd Preparaty koniugatów PEG-interferon alfa
AU2007345347B2 (en) * 2007-01-26 2013-11-07 Synageva Biopharma Corp Transgene expression in avians
EP2170268A2 (en) 2007-06-25 2010-04-07 Amgen, Inc. Compositions of specific binding agents to hepatocyte growth factor
WO2009079837A1 (en) * 2007-12-18 2009-07-02 Hangzhou Jiuyuan Gene Engineering Co., Ltd. A pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein
TR201809898T4 (tr) 2009-11-03 2018-07-23 Grifols Therapeutics Llc Alfa-1 protei̇naz i̇nhi̇bi̇törüne yöneli̇k bi̇leşi̇m, yöntem ve ki̇t.
PT2503995T (pt) 2009-11-24 2017-11-23 Grifols Therapeutics Inc Métodos de liofilização, composições e kits
US20130008191A1 (en) * 2011-07-07 2013-01-10 Suchak Naresh J Methods for freezing and thawing proteins
SI3183264T1 (sl) 2014-08-19 2021-03-31 Biogen Ma Inc. Metoda pegilacije
CN106421755A (zh) * 2016-11-03 2017-02-22 广州凯耀资产管理有限公司 一种干扰素组合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553497A (en) * 1946-02-04 1951-05-15 L Inst De Serotherapie Hemopoi Hemostatic composition of thrombin and glycocoll
US2806815A (en) * 1955-04-12 1957-09-17 Ortho Pharma Corp Stabilized hyaluronidase
GB866423A (en) * 1958-03-21 1961-04-26 Armour & Co Improvements in or relating to chymotrypsin solutions
US3016398A (en) * 1959-04-06 1962-01-09 Staley Mfg Co A E Stabilized phytic acid solutions and methods of preparation thereof
GB900115A (en) * 1960-06-15 1962-07-04 Armour & Co Improvements in or relating to trypsin solutions
JPS5495795A (en) * 1978-01-13 1979-07-28 Toray Ind Inc Production of interferon
IN150740B (no) * 1978-11-24 1982-12-04 Hoffmann La Roche
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation

Also Published As

Publication number Publication date
AU9168882A (en) 1983-06-30
AU558966B2 (en) 1987-02-19
DK565882A (da) 1983-06-24
NO161036C (no) 1989-06-28
PT76013A (en) 1983-01-01
FI70794C (fi) 1986-10-27
DK158771B (da) 1990-07-16
EP0082481B1 (en) 1985-03-13
FI824366L (fi) 1983-06-24
HK94487A (en) 1987-12-18
MY8700705A (en) 1987-12-31
CA1207665A (en) 1986-07-15
DE3262575D1 (en) 1985-04-18
EP0082481A1 (en) 1983-06-29
OA07282A (fr) 1984-11-30
SG70687G (en) 1988-02-19
IL67517A (en) 1988-11-30
EP0082481B2 (en) 1990-09-12
PH19869A (en) 1986-08-13
IE823046L (en) 1983-06-23
FI824366A0 (fi) 1982-12-20
DK158873B (da) 1990-07-30
US4496537A (en) 1985-01-29
NO161036B (no) 1989-03-20
IE54468B1 (en) 1989-10-25
PT76013B (en) 1986-03-11
NZ202856A (en) 1985-12-13
DK158873C (da) 1990-12-31
HU190649B (en) 1986-09-29
IL67517A0 (en) 1983-05-15
FI70794B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
NO824285L (no) Fremgangsmaate ved fremstilling av stabiliserte interferonpreparater.
NO821198L (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO163042C (no) Fremgangsm te ved fremstilling av stabiliserte pge2ndelser.
NO822704L (no) Fremgangsmaate for fremstilling av insulinderivater.
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO166931C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO160205C (no) Fremgangsmaate ved fremstilling av silibininderivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO157422C (no) Fremgangsmaate til fremstilling av anti-t-lymfocytt-globulin.
ES510963A0 (es) Procedimiento de preparacion de alcoxiaminohidridosilanos.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO822808L (no) Fremgangsmaate ved fremstilling av decarboxylaseinhiberende fluorerte alkandiaminoderivater
NO824330L (no) Fremgangsmaate ved fremstilling av arsensyre.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN DECEMBER 2003